Integrated Wealth Concepts’s State Street SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
Other funds holding XBI
JFG
Integrated Wealth Concepts's XBI Position: Q2 2026 in Review
Integrated Wealth Concepts reduced its State Street SPDR S&P Biotech ETF (XBI) stake by 5.6% in Q2 2026, selling an estimated $186K and leaving 23,189 shares worth $3.67M. The position accounts for 0.02% of the portfolio, ranked #607.
Integrated Wealth Concepts first reported a position in XBI in Q1 2020 and has held it in 26 quarters since. 934 funds tracked by Wall St. Rank hold XBI as of Q2 2026.
- Integrated Wealth Concepts held 23,189 shares of State Street SPDR S&P Biotech ETF worth $3.67M as of Q2 2026.
- Integrated Wealth Concepts sold 1,376 State Street SPDR S&P Biotech ETF shares in Q2 2026, an estimated $186K.
- State Street SPDR S&P Biotech ETF made up 0.02% of Integrated Wealth Concepts's portfolio in Q2 2026, its #607 holding.
- Integrated Wealth Concepts first reported a position in State Street SPDR S&P Biotech ETF in Q1 2020 and has held it in 26 quarters since.
- 934 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q2 2026.
Based on Integrated Wealth Concepts's 13F filing for Q2 2026, filed 12 Aug 2026.